Stock Ratings / Consumer Discretionary / BYAH / financials

BNKK (45) CABR (38) YCBD (43) UG (70) ⌘ Pro Terminal →

Park Ha Biological Technology Co. Ltd. (Class A) (BYAH) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$2.30 +1.71% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $2.30

Park Ha Biological Technology Co. Ltd. (Class A) (BYAH) carries a Roarable Rating of D+ (Sell) with 57/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record: Scores of 57/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.2% avg 90D alpha vs SPY) →

ROARABLE D+ • SELL / AVOID Cap $7.9M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $2.30 (+0.12%)🧬 Dilution Drag (+1.36% YoY Shares)⚙️ Cash Engine: 14/20 (B-) • 3.4% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 57/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.2% avg 90D alpha vs SPY • 52.2% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk C-

Each axis scored 0–20

12M PRICE TARGET CONE-0.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BYAH)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (57/100 Composite)

🔍 WHY BYAH SCORES 57/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Cash Engine Quality+14/20 pts (25% of score)

SEC XBRL FY 2025 (10-K): 3.4% FCF Margin ($85.9K FCF) & 94.4% Gross Margin

▲ #2 Bullish Driver: Macro Regime Fit+13/20 pts (23% of score)

FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 42.3 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution7/20 pts (-13 pt drag)

Dilution Drag (+1.36% YoY Shares) & executive Form 4 sales trim 13 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C+$2.53-13% Next Q

Q2 (-2Q)

Grade C+$2.20+5.5% Next Q

Q3 (-1Q)

Grade C$2.32-0.9% Next Q

Current

Grade D+$2.30-0.2% Hist 90D α

Trajectory: C+ (65) → D+ (57)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the BYAH Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 57/100 (D+) score, BYAH faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($2.49) or 200D SMA ($10.86) invalidates the momentum regime and cuts Target Base ($2.29) toward Bear Floor ($1.79).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $BYAH• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “BYAH Beats Next Quarter EPS Consensus (Jan 29, 2027) & Holds Above 200D SMA”

YES 57%NO 43%Trade / Inspect Odds →

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • FY 2025 (10-K)

How BYAH Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$85.9K (3.4% FCF Margin)

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

■ Revenue■ Net Profit■ Free Cash Flow

FY23

Rev $2.5M

FY24

Rev $2.4M

FY25

Rev $2.5M

Fiscal Year	Revenue	Gross Margin	Op Margin	Net Profit	Free Cash Flow	ROIC %
FY 2025	$2.5M	94.4%	-80%	-$24.4M	$85.9K	15%
FY 2024	$2.4M	91.8%	33.3%	$478.6K	$960.5K	15%
FY 2023	$2.5M	92%	48%	$852.0K	$126.5K	15%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BYAH)

✓Walkthrough of BYAH's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

BYAH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -73.74%▲ RESISTANCE BREAKOUT

2026-10-30O $2.21H $2.31L $2.15C $2.30VOL 15.4K

RES: $0.88SUP: $1.60SMA50: $2.49SMA200: $10.86

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BYAH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 BYAH Butterfly Map → + Track BYAH →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BYAH today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BYAH. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for BYAH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BYAH)

Consumer Discretionary Rank #491 of 1011 ⚔️ BNKK vs BYAH Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (BYAH vs. BNKK, CABR, YCBD, UG)

Industry: Package Goods/Cosmetics (23 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Park Ha Biological Technology Co. Ltd. (Class A) (BYAH) ranks #491 by composite RQD confidence (57/100, grade D+) and #945 by equity capitalization ($7.9M). Within this direct 5-issuer industry benchmark cohort, UG leads on earnings valuation at 14.5x trailing P/E, while UG leads on capital efficiency and profitability with 17.8% ROIC and — gross margin. UG currently holds the highest overall quantitative score in the immediate peer group at 70/100 (B-) compared with BYAH at 57/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
BYAH ACTIVE Park Ha Biological Technology Co. Ltd. (Class A)	D+	57/100	—	94.4%	—	+1.71%	$7.9M	Benchmark Subject
BNKK Bonk Inc.	D	45/100	—	58.5%	-35.0%	-2.48%	$9.4M	/bnkk-vs-byah →
CABR Caring Brands Inc.	D-	38/100	—	55.6%	-35.0%	-4.46%	$11.2M	/cabr-vs-byah →
YCBD cbdMD Inc.	D-	43/100	—	62.4%	-30.4%	+4.56%	$4.3M	/ycbd-vs-byah →
UG United-Guardian Inc.	B-	70/100	14.5x	—	17.8%	-1.19%	$30.6M	/ug-vs-byah →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-10-31 • CIK 0001986247

In its most recent audited fiscal period (FY2025, filed 2025-10-31), Park Ha Biological Technology Co. Ltd. (Class A) (BYAH) reported GAAP revenue of $2.5M (+6.0% vs. FY2024 revenue of $2.4M , and +2.7% cumulative change since FY2023) , GAAP net income of -$24.4M, operating cash flow of $85.9K, and free cash flow of $85.9K (-91.1% YoY). On the balance sheet, BYAH closed FY2025 with $6.0M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-10-31	$2.5M	-$24.4M	$85.9K	$85.9K	$6.0M	—
FY2024 (FY)	2024-10-31	$2.4M	$478.6K	$960.5K	$960.5K	—	—
FY2023 (FY)	2023-10-31	$2.5M	$852.0K	$126.5K	$126.5K	—	—

3. BYAH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BYAH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Park Ha Biological Technology Co. Ltd. (Class A) (NASDAQ: BYAH) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 57/100 at a spot price of $2.30 (+1.71% 1D, market cap $7.9M). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 7/20. Across 1011 tracked Consumer Discretionary issuers, BYAH ranks #491 in composite RQD confidence.

How does BYAH compare to BNKK and CABR in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Package Goods/Cosmetics), BYAH carries a Roarable D+ (57/100 RQD), trailing P/E of N/A, gross margin of 94.4%, and ROIC of —. By comparison, BNKK (Bonk Inc.) holds a D grade (45/100 RQD, P/E N/A, ROIC -35.0%, cap $9.4M) and CABR (Caring Brands Inc.) posts a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $11.2M). Among the 5-stock peer group, UG leads on earnings multiple (14.5x) while UG leads on capital efficiency (17.8% ROIC).

What are the biggest fundamental strengths and SEC risk factors for BYAH?

Per BYAH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-10-31, CIK 0001986247), Park Ha Biological Technology Co. Ltd. (Class A) generated $2.5M in revenue (+6.0% YoY), -$24.4M in net income, and $85.9K in free cash flow against $6.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is BYAH trading relative to its 50-day, 200-day, and 52-week technical levels?

BYAH last traded at $2.30 (+1.71% on volume of 2,204 shares), positioning the stock -7.63% below its 50-day simple moving average ($2.49) and -78.82% below its 200-day simple moving average ($10.86). Across its 52-week range of $1.90 to $158.00, BYAH sits at the 0.3% percentile with a 14-day RSI of 42.3 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($2.01 to $2.59).

BYAH Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

How profitable is Park Ha Biological Technology Co. Ltd. (Class A) (BYAH)?

In FY 2025 (10-K), BYAH converted $2.5M of revenue into a 94.4% gross margin, 0% operating margin, and $85852 in free cash flow (3.4% FCF margin).

Direct Sub-Reports: BYAH RQD Cockpit BYAH 12M Forecast BYAH Earnings & Move BYAH Dividends & DRIP BYAH Insiders & 13F BYAH Whale Options BYAH Profit Sankey BYAH News & Why